Use of quality indicators in neuroblastoma treatment: A feasibility assessment
- 31 July 2020
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (9), e28301
- https://doi.org/10.1002/pbc.28301
Abstract
Background Quality indicators (QIs) may be used to monitor the quality of neuroblastoma (NBL) care during treatment, in addition to survival and treatment toxicity, which can only be evaluated in the years after treatment. The present study aimed to assess the feasibility of a new set of indicators for the quality of NBL therapy. Procedure Seven QIs have been proposed based on literature and consensus of experts: (a) duration of complete diagnostic work‐up, (b) prescription of thyroid prophylaxis before metaiodobenzylguanidine imaging, (c) treatment intensity, (d) use of tumor board meetings, (e) number of outpatient visits and sedation procedures during follow‐up, (f) protocolled follow‐up, and (g) required apheresis sessions. A retrospective data analysis from October 2014 to November 2017 including all patients with NBL in the centralized Princess Máxima Center in the Netherlands was performed to assess these parameters and determine practicality of measurement. Results A total number of 72 patients (aged between 2 weeks and 15 years) were analyzed. Adherence to all QIs could be determined for all eligible patients using their electronic medical records. Three indicators were compared over time, and an increase in adherence was observed. Conclusions Assessment of QIs in neuroblastoma treatment is feasible. Seven new QIs were found to be feasible to measure and showed improvement over time for three indicators. Monitoring of these QIs during treatment may provide tools for quality improvement activities and comparisons of treatment quality over time or between centers. Further study is required to investigate their association with long‐term outcomes.This publication has 66 references indexed in Scilit:
- Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certificationArchiv für Gynäkologie, 2012
- A story of success: continuous quality improvement in cystic fibrosis care in the USAThorax, 2011
- Quality Measurement in Cancer Care DeliveryAnnals of Surgical Oncology, 2011
- The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non‐small cell lung cancerInternal Medicine Journal, 2009
- Improving patient survival with the colorectal cancer multi‐disciplinary teamColorectal Disease, 2009
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialThe Lancet Oncology, 2008
- Adverse Events Associated with Procedural Sedation and Analgesia in a Pediatric Emergency Department: A Comparison of Common Parenteral DrugsAcademic Emergency Medicine, 2005
- Measuring the quality of surgical care: structure, process, or outcomes?Journal of the American College of Surgeons, 2004
- PRACTICE GUIDELINES IN PEDIATRIC HEMATOONCOLOGY: Implementation and Survey. A Possible Way for Medical Quality AssurancePediatric Hematology and Oncology, 2000
- Using health outcomes data to compare plans, networks and providersInternational Journal for Quality in Health Care, 1998